The role of neuropeptides in cardiovascular regulation Detlev GantenMartin PaulRudolf E. Lang Reviews Pages: 119 - 130
Coronary effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs Kenji HashimotoMasahiko KinoshitaYasunori Ohbayashi Experimental Pharmacology Pages: 131 - 138
Propionyl-L-carnitine: Biochemical significance and possible role in cardiac metabolism Noris SiliprandiFabio Di LisaRoberta Menabò OriginalPaper Pages: 11 - 15
Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide T. K. KnilansA. VarróD. A. Lathrop Experimental Pharmacology Pages: 139 - 146
Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart R. FerrariE. PasiniO. Visiou OriginalPaper Pages: 17 - 23
Comparative effects of angiotensin converting enzyme inhibition (perindopril) or diuretic therapy on cardiac hypertrophy and sympathetic activity following myocardial infarction in rats Laurence G. HowesG. Peter HodsmanColin I. Johnston ACE Inhibitors Pages: 147 - 152
Effects of some L-carnitine derivatives on heart membrane ATPases Naranjan S. DhallaFrantišek KolárRoberto Ferrari OriginalPaper Pages: 25 - 30
Ambulatory blood pressure monitoring for the evaluation of once-daily ACE inhibition: A comparison study of captopril and enalapril combined with hydrochlorothiazide Audrey von PölnitzHans-Martin LorenzBerthold Höfling Letters to the Editor Pages: 153 - 154
Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma M. BevilacquaT. VagoG. Norbiato OriginalPaper Pages: 31 - 35
Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy D. G. CaralisZ. KyriakidesC. Ioakimides Letters to the Editor Pages: 155 - 156
Effects of propionate on mechanical and metabolic performance in aerobic rat hearts Hakki BolukogluStephen H. NellisA. James Liedtke OriginalPaper Pages: 37 - 43
Nonpharmacologic measures for lowering blood pressure R. B. Singh Letters to the Editor Pages: 157 - 157
Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs Antonio CeveseFederico SchenaGiuliana Cerutti OriginalPaper Pages: 45 - 56
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria R. FerrariC CeconiO. Visioli OriginalPaper Pages: 57 - 65
Potential impact on antoxidants administered unknowingly to experimental animals in laboratory diets Howard J. Smith Letters to the Editor Pages: 159 - 159
Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium Kathryn A. YamadaDavid J. DobmeyerPeter B. Corr OriginalPaper Pages: 67 - 76
Protective effects of propionyl-L-carnitine during ischemia and reperfusion A. ShugD. PaulsonV. Regitz OriginalPaper Pages: 77 - 83
Effect of propionyl-L-carnitine on experimental myocardial infarction in dogs James Edward LeasureKarl Kordenat OriginalPaper Pages: 85 - 95
Torsades de pointes, a quarter of a century later: A tribute to Dr. F. Dessertenne Alexandre FabiatoPhilippe Coumel Forum on Torsades de Pointes Part Two Pages: 167 - 169
Effect of propionyl-L-carnitine on human endothelial cells Victor W. M. van HinsberghMariëlle A. Scheffer OriginalPaper Pages: 97 - 105
A new chapter of electrocardiography: The progressive variations in the amplitude of the electrocardiogram F. DessertenneA. FabiatoP. Coumel Forum on Torsades de Pointes Part Two Pages: 171 - 190
Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function Adele ChiddoAntonio GaglionePaolo Rizzon OriginalPaper Pages: 107 - 111
Torsades de pointes: Arrhythmia, syndrome, or chimera? A perspective in the light of the Lambeth Conventions Michael J. Curtis Forum on Torsades de Pointes Part Two Pages: 191 - 200
Torsades de pointes: Arrhythmia, syndrome, or chimera? R. N. Scott Millar Forum on Torsades de Pointes Part Two Pages: 201 - 202
Electrophysiologic mechanisms involved in the development of torsades de pointes Silvia G. PrioriCarlo NapolitanoPeter J. Schwartz Forum on Torsades de Pointes Part Two Pages: 203 - 212
Scientific Programme of the 4th International Symposium on Cardiovascular Pharmacotherapy Geneva, Switzerland, April 22–25, 1991 Monday, April 22, 1991 Report Pages: 213 - 214